Prospective, Multi-institutional Study Shows CyberKnife SBRT Treatment Results in Low PSA Nadir for Low- and Intermediate-risk Prostate Cancer Patients SUNNYVALE, Calif. , Feb. 16, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today data from a prospective, Phase II, 17-center
SUNNYVALE, Calif. , Feb. 13, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), announced today that Kevin Waters , Senior Vice President and Chief Financial Officer, is scheduled to meet with investors one-on-one at the 2017 RBC Capital Markets Healthcare Conference in New York on
Next-Generation "Smart" TomoTherapy® System Represents Major Step Forward in Treatment Speed, Ease of Use and Adaptive Therapy Capabilities SUNNYVALE, Calif. , Feb. 8, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that it has received Shonin approval from the Japanese
SUNNYVALE, Calif. , Jan. 31, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today financial results for the second fiscal quarter and six months ended December 31, 2016 . Fiscal Second Quarter Highlights Ending backlog increased 16 percent year-over-year to $426.2 million ;
Day 1 Experience Demonstrates the Speed and Efficiency of the New System SUNNYVALE, Calif. , Jan. 26, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Miami Cancer Institute , a part of Baptist Health South Florida, is now treating patients using the new, uniquely
MD Buyline Report Shows Composite Overall User Satisfaction Ratings Exceed Industry Average for 14 Consecutive Quarters SUNNYVALE, Calif. , Jan. 19, 2017 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that its CyberKnife® and TomoTherapy® Systems continue to set the bar for
SUNNYVALE, Calif. , Jan. 17, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its fiscal second quarter ended December 31, 2016 on Tuesday, January 31, 2017 after the market close. Management will host a conference call to review the results at 1:30 p.m.
SUNNYVALE, Calif. , Jan. 10, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Company will present at JP Morgan's 35th Annual Healthcare Conference on Wednesday, January 11, 2017 at the Westin St. Francis Hotel in San Francisco .
Hospital will be the First in Asia to Offer Radixact™ System and CyberKnife® M6™ System Patient Treatments SUNNYVALE, Calif. , Dec. 21, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) has signed an agreement with Hong Kong Sanatorium & Hospital (HKSH) for the acquisition of three
European and U.S. Hospitals Advance Adaptive Cancer Care with Image-Guided Radiation Therapy System SUNNYVALE, Calif. , Dec. 8, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that leading hospitals in Europe and the United States are now treating patients with the new
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
